August 2025
1. ANKER SD, Karakas M, Mentz RJ, Ponikowski P, et al
   Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency.
   Nat Med. 2025;31:2640-2646.
   

   >> Share

   
   July 2025
2. AGARWAL R, Bertaina A, Soco C, Long-Boyle JR, et al
   Irradiation- and busulfan-free stem cell transplantation in Fanconi anemia using an anti-CD117 antibody: a phase 1b trial.
   Nat Med. 2025 Jul 22. doi: 10.1038/s41591-025-03817.
   

   >> Share

   
   
3. GRIMLEY M, Davies SM, Shrestha A, Shova A, et al
   Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trial.
   Nat Med. 2025;31:2204-2212.
   

   >> Share

   
   June 2025
4. LEE S, Son Y, Hwang J, Kim MS, et al
   Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study.
   Nat Med. 2025;31:1809-1829.
   

   >> Share

   
   January 2025
5. PASRICHA SR, Moya E, Ataide R, Mzembe G, et al
   Author Correction: Ferric carboxymaltose for anemia in late pregnancy: a randomized controlled trial.
   Nat Med. 2025 Jan 13. doi: 10.1038/s41591-025-03492.
   

   >> Share

   
   
6. PASRICHA SR, Moya E, Ataide R, Mzembe G, et al
   Ferric carboxymaltose for anemia in late pregnancy: a randomized controlled trial.
   Nat Med. 2025 Jan 6. doi: 10.1038/s41591-024-03385.
   

   >> Share

   
   September 2024
7. BREEYEAR JH, Hellwege JN, Schroeder PH, House JS, et al
   Adaptive selection at G6PD and disparities in diabetes complications.
   Nat Med. 2024;30:2480-2488.
   

   >> Share

   
   November 2023
8. SPENCER CHAPMAN M, Cull AH, Ciuculescu MF, Esrick EB, et al
   Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease.
   Nat Med. 2023 Nov 16. doi: 10.1038/s41591-023-02636.
   

   >> Share

   
   
9. CARVALHO T
   Discontinued CRISPR gene therapy for sickle-cell disease improves symptoms.
   Nat Med. 2023;29:2669-2670.
   

   >> Share

   
   October 2023
10. BAHLIS NJ, Costello CL, Raje NS, Levy MY, et al
    Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial.
    Nat Med. 2023;29:2570-2576.
    

    >> Share

    
    May 2023
11. ABEDINI A, Klotzer KA, Susztak K
    Unmasking the elusive erythropoietin-producing 'Norn' cell.
    Nat Med. 2023 May 2. doi: 10.1038/s41591-023-02322.
    

    >> Share

    
    April 2023
12. KRAGESTEEN BK, Giladi A, David E, Halevi S, et al
    The transcriptional and regulatory identity of erythropoietin producing cells.
    Nat Med. 2023 Apr 27. doi: 10.1038/s41591-023-02314.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share